Cem Gorgun is a physician-scientist and oncology development leader with over 15 years of experience in the biopharmaceutical industry. As a Director at BioNTech, he focuses on immuno-oncology, bispecifics, and first-in-human clinical programs. He completed his post-doctoral fellowship at Harvards T. H. Chan School of Public Health.
Outside of his direct professional responsibilities, he has contributed to philanthropic causes. He is listed as a donor to the Turkish Philanthropy Funds, an organization dedicated to creating lasting change by supporting communities in Turkey and the US.
He has recently co-authored multiple publications on investigational bispecific antibody immunotherapies, including Acasunlimab, for treating metastatic non-small cell lung cancer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.